SVB Securities analyst Roanna Ruiz initiated coverage of ARS Pharmaceuticals with an Outperform rating and $14 price target.
Published first on TheFly
SVB Securities analyst Roanna Ruiz initiated coverage of ARS Pharmaceuticals with an Outperform rating and $14 price target.
Published first on TheFly